Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma. Academic Article uri icon

Overview

publication date

  • November 1, 2013

Research

keywords

  • Carcinoma, Pancreatic Ductal
  • Pancreatic Neoplasms
  • Smad4 Protein

Identity

PubMed Central ID

  • PMC3982289

Scopus Document Identifier

  • 84884827171

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2013.06.2039

PubMed ID

  • 24074918

Additional Document Info

volume

  • 87

issue

  • 3